Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_assertion type Assertion NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_head.
- NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_assertion description "[The current results suggest absence of ERBB-2 overexpression in uterine leiomyosarcoma, uterine adenosarcoma, and endometrial stromal sarcoma, whereas the ERBB-2 gene might have a biologic role in uterine carcinosarcoma and undifferentiated uterine sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_provenance.
- NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_assertion evidence source_evidence_literature NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_provenance.
- NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_assertion SIO_000772 15581967 NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_provenance.
- NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_assertion wasDerivedFrom befree-2016 NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_provenance.
- NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_assertion wasGeneratedBy ECO_0000203 NP471515.RAnd6y4ODQgW0Fd311biq-boFLLBTL3Cz69ObYdabOKf0130_provenance.